JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.